A study has reported that miR-30a-5p, which was upregulated in MPTP-treated mice (a mouse model of PD), decreased GLT-1 expression and function through the ubiquitin-proteasome degradation pathway, thereby participating in the pathological process of PD. Here, SLC1A2 is linked to Parkinson disease.